International Aids Vaccine (IAVI) is a nonprofit scientific research organization based in New York, NY. They are dedicated to developing vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. With a full-circle approach to product development, IAVI works from grassroots levels to legislative bodies to translate scientific discoveries into affordable and globally accessible public health solutions. Their mission is to bring an end to the HIV pandemic and create a world where all people have equitable access to innovative vaccines and therapeutics.
IAVI's work spans various health areas, including HIV, tuberculosis, Lassa fever, Marburg virus, Sudan Ebolavirus, and COVID-19. They are actively addressing the challenges of HIV vaccine design by developing next-generation HIV vaccines and discovering broadly neutralizing antibodies (bnAbs) against HIV. In the fight against tuberculosis, IAVI collaborates with partners globally to advance promising TB vaccine candidates and support policy and advocacy initiatives. Additionally, IAVI is working on developing vaccines for Lassa fever, Marburg virus, and Sudan Ebolavirus, all of which pose significant threats to public health. Through their research and development efforts, IAVI aims to provide effective and accessible solutions to combat these infectious diseases.
Generated from the website